Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials
- Maxime M.A. Verhoeven*
- , Marjolein J.H. De Hair
- , Janneke Tekstra
- , Johannes W.J. Bijlsma
- , Jacob M. Van Laar
- , Attila Pethoe-Schramm
- , Michelle E.A. Borm
- , Evert Jan Ter Borg
- , Suzanne P. Linn-Rasker
- , Xavier M. Teitsma
- , Floris P.J.G. Lafeber
- , Johannes W.G. Jacobs
- , Paco M.J. Welsing
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review